- Home
- STEC vs DYAI Comparison
STEC vs DYAI Comparison
Compare STEC & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEC
- DYAI
- Stock Information
- Founded
- STEC 2006
- DYAI 1979
- Country
- STEC Hong Kong
- DYAI United States
- Employees
- STEC N/A
- DYAI N/A
- Industry
- STEC
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STEC
- DYAI Health Care
- Exchange
- STEC NYSE
- DYAI Nasdaq
- Market Cap
- STEC 29.7M
- DYAI 29.6M
- IPO Year
- STEC 2021
- DYAI 2004
- Fundamental
- Price
- STEC $0.84
- DYAI $0.93
- Analyst Decision
- STEC
- DYAI Strong Buy
- Analyst Count
- STEC 0
- DYAI 1
- Target Price
- STEC N/A
- DYAI $6.00
- AVG Volume (30 Days)
- STEC 15.6K
- DYAI 60.7K
- Earning Date
- STEC 07-15-2025
- DYAI 08-12-2025
- Dividend Yield
- STEC N/A
- DYAI N/A
- EPS Growth
- STEC N/A
- DYAI N/A
- EPS
- STEC N/A
- DYAI N/A
- Revenue
- STEC $10,672,000.00
- DYAI $3,554,344.00
- Revenue This Year
- STEC $9,392.20
- DYAI $22.56
- Revenue Next Year
- STEC N/A
- DYAI $30.95
- P/E Ratio
- STEC N/A
- DYAI N/A
- Revenue Growth
- STEC N/A
- DYAI 57.59
- 52 Week Low
- STEC $0.20
- DYAI $0.91
- 52 Week High
- STEC $3.25
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- STEC 41.37
- DYAI 41.84
- Support Level
- STEC $0.81
- DYAI $0.91
- Resistance Level
- STEC $0.89
- DYAI $1.06
- Average True Range (ATR)
- STEC 0.08
- DYAI 0.06
- MACD
- STEC -0.00
- DYAI 0.00
- Stochastic Oscillator
- STEC 28.92
- DYAI 15.33
About STEC SANTECH HOLDINGS LIMITED
Santech Holdings Ltd is a customer based technology company. The company is engaged in exploring new opportunities in technology that includes new retail, social e-commerce, metaverse and others.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.